ScholarIQanswers from OpenAlex & ORCID
Daniel Eriksson
ResearcherPublications, citations & collaboration network
Daniel Eriksson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel Eriksson have?
ScholarIQindexed works
Daniel Eriksson has 52 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel Eriksson have?
ScholarIQcitation count
Daniel Eriksson has 822 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel Eriksson?
ScholarIQh-index
Daniel Eriksson has an h-index of 14 in OpenAlex.
What is the i10-index of Daniel Eriksson?
ScholarIQi10-index
Daniel Eriksson has an i10-index of 18 in OpenAlex.
What is the ORCID of Daniel Eriksson?
ScholarIQorcid
The ORCID for Daniel Eriksson is on the source record.
What is the OpenAlex record for Daniel Eriksson?
ScholarIQopenalex
The OpenAlex for Daniel Eriksson is on the source record.
What are the most-cited papers on Daniel Eriksson?
ScholarIQmost cited works
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis
Craig I Coleman, Reinhold Kreutz, Nitesh Sood, Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, William L. Baker
Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis
Nicole Hannemann, Shan Cao, Daniel Eriksson, Anne Schnelzer, Jutta Jordan, Martin Eberhardt, Ulrike Schleicher, Jürgen Rech, Andreas Ramming, Steffen Uebe, Arif B. Ekici, Juan D. Cañete, Xiaoxiang Chen, Tobias Bäuerle, Julio Vera, Christian Bogdan, Georg Schett, Aline Bözec
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia
Daniel Eriksson, David Goldsmith, S Teitsson, James Jackson, Floortje van Nooten
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
Adrían V. Hernández, G. Bradley, Mohammad Khan, Andrew J Fratoni, Anna Gasparini, Yuani M. Roman, Thomas J. Bunz, Daniel Eriksson, Anna‐Katharina Meinecke, Craig I Coleman
Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis
Craig I Coleman, Reinhold Kreutz, Nitesh Sood, Thomas J. Bunz, Anna‐Katharina Meinecke, Daniel Eriksson, William L. Baker